Oncogene
Oncogene is a subscription (hybrid open access) journal published by Springer Nature in the United Kingdom. OpenAlex counts 19,558 works from it, cited 1,917,138 times; its h-index is 453. Its two-year mean citedness, which is computed the way the impact factor is, is 8.75: a paper it published in the two years before was cited about 8.75 times last year. It published 403 papers in 2025, up 19% from 339 in 2024. Publishing a paper open access in it costs about US$5,990.
- Publisher
- Springer Nature
- Citations per paper
- 8.75 two-year mean, OpenAlex
- h-index
- 453 i10-index 17,810
- Access
- Subscription · hybrid open access
- APC
- US$5,990 to publish open access
- ISSN
- 0950-9232, 1476-5594
- Country
- United Kingdom
- Works published
- 19,558 cited 1,917,138 times
- Papers in 2025
- 403
- Field
- Medicine
- Website
- Journal home ↗
Oncogene year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 373 | 57,651 |
| 2025 | 403 | 71,118 |
| 2024 | 339 | 82,878 |
| 2023 | 323 | 89,783 |
| 2022 | 447 | 94,010 |
| 2021 | 540 | 102,548 |
| 2020 | 443 | 93,547 |
| 2019 | 513 | 83,077 |
What Oncogene publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Cancer-related Molecular PathwaysOncology · 5,021 papers
- Protein Kinase Regulation and GTPase SignalingMolecular Biology · 2,585 papers
- Cell death mechanisms and regulationMolecular Biology · 2,045 papers
- Genomics and Chromatin DynamicsMolecular Biology · 1,522 papers
- Cancer Cells and MetastasisOncology · 1,514 papers
Questions about Oncogene
What is the impact factor of Oncogene?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 8.75 for Oncogene: on average, each paper it published in the two years before was cited about 8.75 times in a year.
What is the h-index of Oncogene?
453, by OpenAlex's count: 453 of its papers have each been cited at least 453 times. Its i10-index is 17,810.
Is Oncogene open access?
Not fully. Oncogene is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the publication fee (APC) of Oncogene?
About US$5,990, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Oncogene?
Its linking ISSN is 0950-9232; all its ISSNs: 0950-9232, 1476-5594.
Who publishes Oncogene?
Springer Nature, based in the United Kingdom.
How many papers does Oncogene publish a year?
403 in 2025, by OpenAlex's count of what it published that year.
What does Oncogene publish?
Its most frequent research topics are Cancer-related Molecular Pathways, Protein Kinase Regulation and GTPase Signaling, Cell death mechanisms and regulation, in the field of Medicine.
Is Oncogene a predatory journal?
Nothing in the scholarly indexes suggests so. Oncogene is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 19,558 works cited 1,917,138 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Oncogene indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (0950-9232): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Oncogene
Other Medicine journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).